Drug recall D-0306-2020
Product
Cefdinir for Oral Suspension USP, 125 mg/5mL, packaged in a) 60 mL bottle (NDC 68180-722-20), b) 100 mL bottle (NDC 68180-722-10), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA
Reason for recall
Presence of Foreign substance: identified as a dead ant.
Lots and codes
Lot #: a) F900153, Exp 11/20; b) F802327, F802328, F802329, Exp 11/20
Recall details
- Recalling firm
- Lupin Pharmaceuticals Inc., Baltimore, MD
- Quantity
- a) 4074 bottles b) 30,300 bottles
- Distribution
- Product was distributed to major distributors/wholesalers throughout the United States.
- Type
- Voluntary: Firm initiated
- Recall initiated
- November 1, 2019
- Terminated
- March 4, 2021
Related products
- Cefdinir – drug information
- NDC 68180-723 Cefdinir · Cefdinir 250 mg/5mL · Lupin Pharmaceuticals, Inc.
- NDC 68180-722 Cefdinir · Cefdinir 125 mg/5mL · Lupin Pharmaceuticals, Inc.